PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.\', \'Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong.\', \'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.\', \'Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.\', \'The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.\', \'Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.\', \'Center for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.\', \'Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.\', \'The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, SAR, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/eji.202149234
?:doi
?:hasPublicationType
?:journal
  • European journal of immunology
is ?:pmid of
?:pmid
?:pmid
  • 34089541
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.206
?:rankingScore_hIndex
  • 185
is ?:relation_isRelatedTo_publication of
?:title
  • Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all